PTC Therapeutics, Inc. provided earnings guidance for the year 2022. For the year 2022, the company anticipates total revenues for the full year 2022 to be between $700 and $750 million. The company anticipated net product revenues for the DMD franchise for the full year 2022 to be between $475 and $495 million.